496 GENES FOUNDi
Show / hide columns XML | RDF | TSV | « prev | Page of 10 | next »
Genei Gene descriptioni x Protein classi x Tissue Cell Pathology Subcellular locationi x RNA tissue categoryi x
KCNA5Potassium voltage-gated channel subfamily A member 5Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNA6Potassium voltage-gated channel subfamily A member 6FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Not detected
KCNB1Potassium voltage-gated channel subfamily B member 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNB2Potassium voltage-gated channel subfamily B member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleoli
Plasma membrane
Midbody
Tissue enhanced
KCNC1Potassium voltage-gated channel subfamily C member 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Nucleus
Nuclear membrane
Vesicles
Cytosol
Tissue enriched
KCNC2Potassium voltage-gated channel subfamily C member 2FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Plasma membrane
Cytosol
Tissue enriched
KCNC3Potassium voltage-gated channel subfamily C member 3Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND1Potassium voltage-gated channel subfamily D member 1FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
NucleusMixed
KCND2Potassium voltage-gated channel subfamily D member 2Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCND3Potassium voltage-gated channel subfamily D member 3Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNJ1Potassium voltage-gated channel subfamily J member 1Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enriched
KCNJ11Potassium voltage-gated channel subfamily J member 11Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNJ12Potassium voltage-gated channel subfamily J member 12FDA approved drug targets
Predicted membrane proteins
Voltage-gated ion channels
Nucleoplasm
Golgi apparatus
Cytosol
Group enriched
KCNJ8Potassium voltage-gated channel subfamily J member 8Disease related genes
FDA approved drug targets
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Mixed
KCNMA1Potassium calcium-activated channel subfamily M alpha 1Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Voltage-gated ion channels
Tissue enhanced
KCNN4Potassium calcium-activated channel subfamily N member 4Disease related genes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ1Potassium voltage-gated channel subfamily Q member 1Disease related genes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Tissue enhanced
KCNQ2Potassium voltage-gated channel subfamily Q member 2Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Transporters
Voltage-gated ion channels
Endoplasmic reticulumTissue enriched
KDRKinase insert domain receptorCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Plasma membraneTissue enhanced
KEAP1Kelch like ECH associated protein 1Cancer-related genes
FDA approved drug targets
Predicted intracellular proteins
Nucleoplasm
Microtubule organizing center
Cytosol
Expressed in all
KITKIT proto-oncogene receptor tyrosine kinaseCancer-related genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
RAS pathway related proteins
Plasma membraneTissue enhanced
LCKLCK proto-oncogene, Src family tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Golgi apparatusTissue enhanced
LHCGRLuteinizing hormone/choriogonadotropin receptorDisease related genes
FDA approved drug targets
G-protein coupled receptors
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
Tissue enhanced
LIPFLipase F, gastric typeEnzymes
FDA approved drug targets
Predicted secreted proteins
Tissue enriched
LPLLipoprotein lipaseCandidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
VesiclesTissue enhanced
MAOAMonoamine oxidase ADisease related genes
Enzymes
FDA approved drug targets
Predicted membrane proteins
MitochondriaMixed
MAOBMonoamine oxidase BEnzymes
FDA approved drug targets
Predicted membrane proteins
Nucleoli
Mitochondria
Mixed
MAP1AMicrotubule associated protein 1AFDA approved drug targets
Plasma proteins
Predicted intracellular proteins
CytosolTissue enriched
MAP2Microtubule associated protein 2FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nucleoli
Cytosol
Tissue enriched
MAP2K1Mitogen-activated protein kinase kinase 1Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
Plasma membrane
Cytosol
Expressed in all
MAP2K2Mitogen-activated protein kinase kinase 2Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
CytosolExpressed in all
MAP4Microtubule associated protein 4FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Microtubules
Cytosol
Expressed in all
MAPK1Mitogen-activated protein kinase 1Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
RAS pathway related proteins
Expressed in all
MAPK11Mitogen-activated protein kinase 11Enzymes
FDA approved drug targets
Predicted intracellular proteins
MitochondriaMixed
MAPK3Mitogen-activated protein kinase 3Cancer-related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
RAS pathway related proteins
NucleoplasmExpressed in all
MAPTMicrotubule associated protein tauCandidate cardiovascular disease genes
Disease related genes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Nuclear speckles
Plasma membrane
Tissue enriched
METMET proto-oncogene, receptor tyrosine kinaseCancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Predicted secreted proteins
RAS pathway related proteins
Plasma membrane
Cytosol
Expressed in all
METAP2Methionyl aminopeptidase 2Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Plasma membrane
Cytosol
Expressed in all
MGAMMaltase-glucoamylaseEnzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Tissue enhanced
MMEMembrane metalloendopeptidaseCancer-related genes
Candidate cardiovascular disease genes
CD markers
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Tissue enhanced
MMP1Matrix metallopeptidase 1Cancer-related genes
Candidate cardiovascular disease genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted secreted proteins
VesiclesTissue enhanced
MMP10Matrix metallopeptidase 10Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Plasma membrane
Cytosol
Tissue enriched
MMP11Matrix metallopeptidase 11Cancer-related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Group enriched
MMP14Matrix metallopeptidase 14Cancer-related genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted membrane proteins
Predicted secreted proteins
Intermediate filaments
Cytosol
Mixed
MMP15Matrix metallopeptidase 15Cancer-related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted membrane proteins
Nucleoplasm
Plasma membrane
Cytosol
Tissue enhanced
MMP16Matrix metallopeptidase 16Cancer-related genes
Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted membrane proteins
Vesicles
Cytosol
Tissue enhanced
MMP19Matrix metallopeptidase 19Disease related genes
Enzymes
FDA approved drug targets
Predicted secreted proteins
Endoplasmic reticulum
Vesicles
Tissue enhanced
MMP2Matrix metallopeptidase 2Cancer-related genes
Candidate cardiovascular disease genes
Disease related genes
Enzymes
FDA approved drug targets
Plasma proteins
Predicted intracellular proteins
Predicted secreted proteins
Vesicles
Cytosol
Tissue enhanced
MMP24Matrix metallopeptidase 24Enzymes
FDA approved drug targets
Predicted membrane proteins
Nucleoli
Plasma membrane
Tissue enhanced
MMP25Matrix metallopeptidase 25Enzymes
FDA approved drug targets
Predicted intracellular proteins
Predicted secreted proteins
Tissue enhanced
« prev | Page of 10 | next »